The Impact of the COVID-19 Lockdown on the Quality of Life in Chronic Neurological Diseases: The Results of a COVQoL-CND Study

Simple item page
dc.contributor.authorSahin S.
dc.contributor.authorKarsidag S.
dc.contributor.authorCinar N.
dc.contributor.authorAtes M.F.
dc.contributor.authorDemir S.
dc.contributor.authorEren F.
dc.contributor.authorNeyal A.
dc.contributor.authorKisabay Ak A.
dc.contributor.authorBora Tokcaer A.
dc.contributor.authorErkoc Ataoglu E.
dc.contributor.authorAkkaya S.N.
dc.contributor.authorAciman Demirel E.
dc.contributor.authorKoc F.
dc.contributor.authorOzturk S.
dc.contributor.authorEkmekyapar Firat Y.
dc.contributor.authorOkluoglu T.
dc.contributor.authorTogrol E.
dc.contributor.authorErdemoglu A.K.
dc.contributor.authorErgin N.
dc.contributor.authorSayin R.
dc.contributor.authorDemir A.
dc.contributor.authorYilmaz S.E.
dc.date.accessioned2024-07-22T08:05:22Z
dc.date.available2024-07-22T08:05:22Z
dc.date.issued2021
dc.description.abstractBackground: Coronavirus disease 2019 (COVID-19) pandemic and lockdown period may induce an impairment in quality of life (QoL), disruption in treatment (DIT), and posttraumatic stress disorder (PTSD) in chronic neurological diseases (CNDs). To reach this information, a multicenter, cross-sectional study (COVQoL-CND) was planned. Parkinson's disease (PD), headache (HA), multiple sclerosis (MS), epilepsy (EP), polyneuropathy (PNP), and cerebrovascular disease (CVD) were selected as the CND. Methods: The COVQoL-CND study includes demographic data, the World Health Organization Quality of Life short form (WHOQOL-BREF), and Impact of Event Scale-Revised (IES-R) forms. Results: The mean age of a total of 577 patients was 49 ± 17 (19-87 years), and the ratio of female/male was 352/225. The mean age of patients with PD, HA, MS, EP, PNP, and CVD were 65 ± 11, 39 ± 12, 38 ± 10, 47 ± 17, 61 ± 12, and 60 ± 15 years, respectively. The IES-R scores were found to be higher in the younger group, those with comorbid disease, contacted with CO-VID-19 patients, or diagnosed with COVID-19. In the group with a high IES-R score, the rate of DIT was found to be high. IES-R scores were negatively correlated with QoL. IES-R total scores were found highest in the CVD group and lowest in the PD group. The ratio of DIT was found highest in the PNP group and the lowest in the EP group. Contact with CO-VID-19 patients was high in the EP and HA group. Conclusions: The results of the COVQoL-CND study showed that lockdown causes posttraumatic stress and deterioration in the QoL in CND. © 2021
dc.identifier.DOI-ID10.1159/000517380
dc.identifier.issn00143022
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13105
dc.language.isoEnglish
dc.publisherS. Karger AG
dc.rightsAll Open Access; Hybrid Gold Open Access
dc.subjectCommunicable Disease Control
dc.subjectCOVID-19
dc.subjectCross-Sectional Studies
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectQuality of Life
dc.subjectSARS-CoV-2
dc.subjectSurveys and Questionnaires
dc.subjectimmunoglobulin
dc.subjectadult
dc.subjectaged
dc.subjectArticle
dc.subjectavoidance behavior
dc.subjectcerebrovascular disease
dc.subjectcoronavirus disease 2019
dc.subjectcross-sectional study
dc.subjectdisease severity
dc.subjectemergency ward
dc.subjectepilepsy
dc.subjectfear
dc.subjectfemale
dc.subjectheadache
dc.subjecthuman
dc.subjectImpact of Events Scale
dc.subjectinternational normalized ratio
dc.subjectLikert scale
dc.subjectlockdown
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmulticenter study
dc.subjectmultiple sclerosis
dc.subjectneurologic disease
dc.subjectParkinson disease
dc.subjectpolyneuropathy
dc.subjectposttraumatic stress disorder
dc.subjectpsychosis
dc.subjectquality of life
dc.subjectquestionnaire
dc.subjectWHOQOL-BREF
dc.subjectclinical trial
dc.subjectcommunicable disease control
dc.titleThe Impact of the COVID-19 Lockdown on the Quality of Life in Chronic Neurological Diseases: The Results of a COVQoL-CND Study
dc.typeArticle

Files

Collections

Scopus Koleksiyonu